CD277 Monoclonal Antibody (eBioBT3.1 (20.1, BT3.1)) (14-2779-82)

Antibody Tumor Targeting Is Enhanced by CD27 Agonists through

CD27 Monoclonal Antibody (O323), FITC (11-0279-42)

CD27 Monoclonal Antibody (O323), FITC (11-0279-42)

WO2020033925A9 - Antibodies that bind cd277 and uses thereof

CD279 (PD-1) Monoclonal Antibody (J43) (14-9985-82)

CD27 Monoclonal Antibody (LG.7F9), PE (12-0271-82)

Anti-BTN3A1 Antibodies

WO2020033925A9 - Antibodies that bind cd277 and uses thereof

CD279 (PD-1) Monoclonal Antibody (eBioJ105 (J105)) (14-2799-80)

InVivoMAb anti-mouse CD27

CD27 Monoclonal Antibody (O323), PE-Cyanine7 (25-0279-42)

CD27 Monoclonal Antibody (O323), APC-eFluor™ 780 (47-0279-42)

Anti-BTN3A1 Antibodies

CD279 (PD-1) Monoclonal Antibody (J43) (14-9985-82)